Signal Patients increasingly ask doctors for a named GLP-1 brand

Summary

PwC reports, citing Jeppe Theisen of Novo Nordisk, that patients are increasingly asking doctors for GLP-1 treatment or even a specific brand. Novo Nordisk manufactures GLP-1 drugs including Ozempic and Wegovy. The report treats this as evidence that consumer interest is pulling the category through the healthcare system from the patient side. It reverses the usual pattern in which clinicians initiate treatment decisions. Theisen adds, however, that clear pathways to a prescription remain scarce, so patients are finding their own routes.